MDMA‐Assisted Psychotherapy for Treatment of Posttraumatic Stress Disorder: A Systematic Review With Meta‐Analysis
The Journal of Clinical Pharmacology October 28, 2021 K W Smith, Dakota Sicignano, Adrían V. Hernández et al. 136 citations
Abstract This article discusses current literature on the use of 3,4‐methylenedioxymethamphetamine (MDMA)‐assisted psychotherapy in the treatment of posttraumatic stress disorder (PTSD). MDMA, the intended active ingredient in illicit Ecstasy or Molly products, is a psychedelic that causes an elevated mood, feeling of bonding, and increased energy. In MDMA‐assisted psychotherapy, patients are...
DOI: 10.1002/jcph.1995 (opens in new tab)
MDMA
Ecstasy
Psychotherapist
Mood
+1